These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10327156)

  • 21. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
    Hosomi N; Ban CR; Naya T; Takahashi T; Guo P; Song XY; Kohno M
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):959-67. PubMed ID: 15729288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo neutralization of P-selectin inhibits leukocyte-endothelial interactions in retinal microcirculation during ocular inflammation.
    Miyamoto K; Ogura Y; Hamada M; Nishiwaki H; Hiroshiba N; Tsujikawa A; Mandai M; Suzuma K; Tojo SJ; Honda Y
    Microvasc Res; 1998 May; 55(3):230-40. PubMed ID: 9657923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of anti-intercellular adhesion molecule-1 antibody on reperfusion injury induced by late reperfusion in the rat middle cerebral artery occlusion model.
    Kanemoto Y; Nakase H; Akita N; Sakaki T
    Neurosurgery; 2002 Oct; 51(4):1034-41; discussion 1041-2. PubMed ID: 12234414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats.
    Zhang J; Takahashi HK; Liu K; Wake H; Liu R; Maruo T; Date I; Yoshino T; Ohtsuka A; Mori S; Nishibori M
    Stroke; 2011 May; 42(5):1420-8. PubMed ID: 21474801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atorvastatin Pretreatment Attenuates Ischemic Brain Edema by Suppressing Aquaporin 4.
    Cheng ZJ; Dai TM; Shen YY; He JL; Li J; Tu JL
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3247-3255. PubMed ID: 30093197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.
    Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S
    Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infiltration of invariant natural killer T cells occur and accelerate brain infarction in permanent ischemic stroke in mice.
    Wang ZK; Xue L; Wang T; Wang XJ; Su ZQ
    Neurosci Lett; 2016 Oct; 633():62-68. PubMed ID: 27637387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat.
    Zhang RL; Zhang ZG; Chopp M
    Neurology; 1999 Jan; 52(2):273-9. PubMed ID: 9932943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
    Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
    Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the Inhibition of Hydrogen Sulfide Synthesis on Ischemic Injury and Oxidative Stress Biomarkers in a Transient Model of Focal Cerebral Ischemia in Rats.
    Hadadha M; Vakili A; Bandegi AR
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2676-84. PubMed ID: 26476584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of P-selectin attenuates neutrophil-mediated myocardial dysfunction in isolated rat heart.
    Ohnishi M; Yamada K; Morooka S; Tojo SJ
    Eur J Pharmacol; 1999 Feb; 366(2-3):271-9. PubMed ID: 10082209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion.
    Ishikawa M; Cooper D; Arumugam TV; Zhang JH; Nanda A; Granger DN
    J Cereb Blood Flow Metab; 2004 Aug; 24(8):907-15. PubMed ID: 15362721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat.
    Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    Brain Res Bull; 2017 Oct; 135():62-68. PubMed ID: 28964774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor.
    Foster KA; Regan HK; Danziger AP; Detwiler T; Kwon N; Rickert K; Lynch JJ; Regan CP
    Neurosci Res; 2009 Jan; 63(1):10-6. PubMed ID: 18951929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke.
    Mocco J; Choudhri T; Huang J; Harfeldt E; Efros L; Klingbeil C; Vexler V; Hall W; Zhang Y; Mack W; Popilskis S; Pinsky DJ; Connolly ES
    Circ Res; 2002 Nov; 91(10):907-14. PubMed ID: 12433835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury.
    Chen Y; Ruetzler C; Pandipati S; Spatz M; McCarron RM; Becker K; Hallenbeck JM
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15107-12. PubMed ID: 14645708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia.
    Briyal S; Shah S; Gulati A
    Neuroscience; 2014 Dec; 281():269-81. PubMed ID: 25301749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin by down-regulating NF-kB and elevating Nrf2, reduces brain edema and neurological dysfunction after cerebral I/R.
    Li W; Suwanwela NC; Patumraj S
    Microvasc Res; 2016 Jul; 106():117-27. PubMed ID: 26686249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anesthesia-Induced Hypothermia Attenuates Early-Phase Blood-Brain Barrier Disruption but Not Infarct Volume following Cerebral Ischemia.
    Liu YC; Lee YD; Wang HL; Liao KH; Chen KB; Poon KS; Pan YL; Lai TW
    PLoS One; 2017; 12(1):e0170682. PubMed ID: 28118390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
    Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.